The China Patent Award is the highest government award in the patent field in China and is regarded as an important reference for measuring the quality of independent innovation in various industries. Here’s a systematic review and statistical analysis of automotive industry award-winning patents fr

On June 16, 2026, under the witness of Chinese President Xi Jinping and President of Myanmar Min Aung Hlaing, Shen Changyu, Commissioner of the China National Intellectual Property Administration (CNIPA), and U Tun Ohn, Union Minister for Commerce of Myanmar, signed a Memorandum of Understanding (Mo

On June 15, 2026, Harbour BioMed Holdings Limited (hereinafter "Harbour BioMed") issued an announcement disclosing the latest ruling in its U.S. patent infringement litigation against Amgen Inc. and its subsidiary Teneobio (together, "Amgen"): a federal jury has found that Amgen willfully infringed

On June 9, 2026, the German Federal Patent Court held an invalidity hearing for EP2947606 ("Mobile terminal") and declared the patent invalid. All auxiliary requests filed by the patentee, Nera Innovations, were rejected. A written judgment is expected to be issued in the coming months.Since the pro

The anti-suit injunction (ASI) originated in English based on principles of equity, which is an important judicial strategy for countries to take the initiative and gain a competitive advantage in the global game of jurisdictional competition.Relevant background:China currently has no statutory ASI